- Datum29.01.2025
- Uhrzeit15:00 - 15:30 Uhr
- Veranstalter
stock3
Bastian Galuschka
Moderator
Sino Biopharmaceutical Ltd. Aktie
Verkaufen
Kaufen
Sino Biopharmaceutical Ltd. Chart
stock3 TerminalDu willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen
Sino Biopharmaceutical Ltd. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (L&S)
0,00 %
Intraday
-3,02 %
1 Woche
-10,41 %
1 Monat
-9,95 %
Seit Jahresbeginn
-1,40 %
1 Jahr
-47,86 %
3 Jahre
-71,30 %
5 Jahre
Wikifolio
Passender Service zu Sino Biopharmaceutical Ltd.
Webinar zu Sino Biopharmaceutical Ltd.
Kursinformationen (L&S)
- Tagestief / Hoch (€)-
- 52W-Tief / Hoch (€)0,269-0,479
- Jahrestief / Hoch (€)0,346-0,385
- Schlusskurs (Vortag)
- Eröffnungskurs
Wichtigste Eigenschaften
Dividenden von Sino Biopharmaceutical Ltd.
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| - | 2027 (e) | ||
| - | 2026 (e) | ||
| - | 2025 (e) | ||
| 10.09.2024 | 2024 | 0,03 $ | 0,97 % |
| 11.06.2024 | 2023 | 0,03 $ | 1,05 % |
| 04.10.2023 | 2023 | 0,02 $ | 0,74 % |
| 20.06.2023 | 2022 | 0,06 $ | 1,62 % |
| 06.09.2022 | 2022 | 0,06 $ | 1,52 % |
| 13.09.2021 | 2021 | 0,02 $ | 0,30 % |
| 15.06.2022 | 2021 | 0,04 $ | 0,99 % |
| 18.06.2021 | 2020 | 0,02 $ | 0,26 % |
| 18.06.2021 | 2020 | 0,02 $ | 0,26 % |
| 11.12.2020 | 2020 | 0,02 $ | 0,30 % |
| 14.09.2020 | 2019 | 0,02 $ | 0,23 % |
| 12.06.2020 | 2019 | 0,04 $ | 0,31 % |
| 10.12.2019 | 2019 | 0,02 $ | 0,20 % |
| 12.09.2019 | 2019 | 0,02 $ | 0,19 % |
| 14.06.2019 | 2018 | 0,04 $ | 0,58 % |
| 04.06.2018 | 2018 | 0,02 $ | 0,10 % |
| 11.09.2018 | 2018 | 0,02 $ | 0,23 % |
| 05.12.2018 | 2018 | 0,02 $ | 0,29 % |
| 04.06.2018 | 2017 | 0,02 $ | 0,10 % |
| 28.11.2017 | 2017 | 0,02 $ | 0,19 % |
| 12.09.2017 | 2017 | 0,02 $ | 0,28 % |
| 06.07.2017 | 2017 | 0,015 $ | 0,23 % |
| 28.06.2017 | 2016 | 0,015 $ | 0,23 % |
| 05.12.2016 | 2016 | 0,015 $ | - |
| 12.09.2016 | 2016 | 0,015 $ | - |
| 28.06.2016 | 2015 | 0,015 $ | - |
| 17.06.2016 | 2015 | 0,015 $ | - |
| 03.12.2015 | 2015 | 0,01 $ | - |
| 10.09.2015 | 2015 | 0,015 $ | - |
| 19.06.2015 | 2015 | 0,015 $ | - |
| 11.09.2014 | 2014 | 0,015 $ | - |
| 02.12.2014 | 2014 | 0,015 $ | - |
| 09.06.2015 | 2014 | 0,015 $ | - |
| 19.06.2014 | 2014 | 0,015 $ | - |
| 05.06.2014 | 2013 | 0,02 $ | - |
| 02.12.2013 | 2013 | 0,01 $ | - |
| 16.09.2013 | 2013 | 0,01 $ | - |
| 13.06.2013 | 2013 | 0,01 $ | - |
| 06.06.2013 | 2012 | 0,02 $ | - |
| 04.12.2012 | 2012 | 0,01 $ | - |
| 11.09.2012 | 2012 | 0,01 $ | - |
| 12.06.2012 | 2012 | 0,01 $ | - |
| 05.06.2012 | 2011 | 0,01 $ | - |
| 09.06.2011 | 2011 | 0,02 $ | - |
| 12.09.2011 | 2011 | 0,02 $ | - |
| 06.12.2011 | 2011 | 0,02 $ | - |
| 26.05.2011 | 2010 | 0,02 $ | - |
| 02.12.2010 | 2010 | 0,02 $ | - |
| 08.09.2010 | 2010 | 0,02 $ | - |
| 14.06.2010 | 2010 | 0,02 $ | - |
| 26.11.2009 | 2009 | 0,015 $ | - |
| 24.09.2009 | 2009 | 0,015 $ | - |
| 03.06.2010 | 2009 | 0,02 $ | - |
| 26.05.2009 | 2008 | 0,015 $ | - |
| 03.12.2008 | 2008 | 0,01 $ | - |
| 18.09.2008 | 2008 | 0,015 $ | - |
| 02.06.2008 | 2008 | 0,015 $ | - |
| 31.05.2007 | 2007 | 0,01 $ | - |
| 19.09.2007 | 2007 | 0,015 $ | - |
| 28.11.2007 | 2007 | 0,015 $ | - |
| 18.06.2008 | 2007 | 0,02 $ | - |
| 12.06.2007 | 2006 | 0,02 $ | - |
| 04.12.2006 | 2006 | 0,01 $ | - |
| 29.09.2006 | 2006 | 0,01 $ | - |
| 08.06.2006 | 2006 | 0,01 $ | - |
| 26.05.2006 | 2005 | 0,015 $ | - |
| 25.11.2005 | 2005 | 0,065 $ | - |
| 13.10.2005 | 2005 | 0,015 $ | - |
| 26.05.2005 | 2005 | 0,02 $ | - |
| 16.09.2004 | 2004 | 0,02 $ | - |
| 06.05.2005 | 2004 | 0,04 $ | - |
Termine von Sino Biopharmaceutical Ltd.
- Mär28Sino Biopharmaceutical Ltd.Q4 2024 Earnings Release
- Aug28Sino Biopharmaceutical Ltd.Q2 2025 Earnings Release
- Mär27Sino Biopharmaceutical Ltd.Q4 2025 Earnings Release
Beschreibung
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
